This inventor holds 94 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Antibacterial Compounds (CPC class C07D-). Top assignees: Allergan, Inc., Allergan Sales, Inc., Agouron Pharmaceuticals, Inc.. Active years: 1996-2026.
Inventors with similar research interests:
Location History:
- Irvine, CA (US) (1996)
- Aliso Viejo, CA (US) (1996 - 2004)
- Aliso Veijo, CA (US) (2005)
- San Diego, CA (US) (1999 - 2023)
Company Filing History:
36 out of 2,287 
24 out of 228 
8 out of 174 
Years Active: 1996-2026
Areas of Expertise:
Title: Min Teng: A Pioneer in Pharmaceutical Innovations
Introduction: Min Teng, a distinguished inventor based in Aliso Viejo, California, holds an impressive portfolio of 92 patents. His innovative contributions primarily focus on advancements in the field of pharmaceuticals, particularly in the treatment of gram-negative bacterial infections and the development of protein kinase C inhibitors.
Latest Patents: Among Min Teng's latest patents are "LpxC inhibitors and uses thereof," which details the development of LpxC inhibitor compounds. These compounds are accompanied by pharmaceutical compositions that aim to treat diseases benefiting from LpxC inhibition, including various urinary tract infections stemming from gram-negative bacteria. Another significant patent is for "Substituted N-pyrimidin-4-yl-3-aminopyrrolo[3,4-C]pyrazoles as protein kinase C inhibitors." This invention outlines the use of specific compounds that inhibit protein kinase C beta II, offering new avenues for therapeutic intervention.
Career Highlights: Throughout his career, Min Teng has made significant strides in the pharmaceutical industry. He has been associated with well-known companies such as Allergan and Allergan Sales, where his work has contributed to groundbreaking pharmaceutical developments.
Collaborations: Min Teng has worked alongside esteemed colleagues, including Roshantha A. Chandraratna and Richard L. Beard. Their collaborations have led to innovative solutions and advancements in the medical field, showcasing the power of teamwork in bringing forth new inventions.
Conclusion: Min Teng's robust body of work exemplifies his dedication to innovation in pharmaceuticals. His patents not only highlight his expertise as an inventor but also underscore the importance of developing effective treatments for prevalent medical conditions. As he continues to push the boundaries of scientific research, his contributions remain vital to the ongoing fight against bacterial infections and other related health concerns.